Guangxi LiuYao Group Co., Ltd (SHA:603368)
China · Delayed Price · Currency is CNY 16.92
+0.06 (0.36%)
May 8, 2026, 3:00 PM CST
Guangxi LiuYao Group Market Cap
Guangxi LiuYao Group has a market cap or net worth of 6.58 billion as of May 8, 2026. Its market cap has increased by 3.47% in one year.
Market Cap
6.58B
Enterprise Value
9.14B
Revenue
20.99B
Ranking
n/a
PE Ratio
9.92
Stock Price
16.92
Market Cap Chart
Since December 4, 2014, Guangxi LiuYao Group's market cap has increased from 4.25B to 6.58B, an increase of 54.98%. That is a compound annual growth rate of 3.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 6.56B | -5.38% |
| Dec 31, 2025 | 6.93B | -2.61% |
| Dec 31, 2024 | 7.12B | 4.58% |
| Dec 29, 2023 | 6.81B | 0.66% |
| Dec 30, 2022 | 6.76B | -1.81% |
| Dec 31, 2021 | 6.89B | -11.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 57.50B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 35.13B |
| Jointown Pharmaceutical Group | 25.23B |
| China National Medicines Corporation | 21.52B |
| Liaoning Cheng Da | 18.24B |
| China Meheco Group | 15.51B |
| Qingdao Baheal Medical INC. | 13.10B |
| China National Accord Medicines Corporation | 12.76B |